Draeger's inaccurate dosage calculations result in recall

The FDA has issued a Class I recall of the Draeger Medical's Infinity Acute Care System monitoring tool, which was manufactured between March and September. The product was distributed solely to the Rush University Medical Center in Chicago.

The Infinity Acute Care System monitoring tool was recalled because the patient monitoring product's “weight-based dosage calculation may indicate incorrect recommended values.”

According to an FDA statement, a letter was sent to Rush University to alert employees to ensure that drug dosages were calculated clearly.


Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.